JPM26 – Talk Bio

Actionable Insights Powered by AI

JPM26 Live Blog Day 2: GSK Stays the Course Amid Key Biopharma Updates

13 hours ago talkbio0Tagged AstraZeneca, Day 2, J.P. Morgan Healthcare Conference, JPM26, Nordisk, SmithKline Beecham

JPM26; GSK; J.P. Morgan Healthcare Conference; Day 2; AstraZeneca; Novo Nordisk; biotech

JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff

14 hours ago talkbio0Tagged JPM26, Metsera, Obesity drugs, Patent Cliff, Pfizer, Phase 3 Clinical Trials

Pfizer; Obesity Drugs; Metsera; Phase III Trials; Albert Bourla; JPM26; Patent Cliff

JPM26: BMS Highlights Early-Stage Bets and Pipeline Progress Amid Late-Stage Pharma Focus

14 hours ago talkbio0Tagged Admilparant, Burning Mouth Syndrome, Camzyos, Cobenfy, Early-stage, JPM26, milvexian, pipeline, pumitamig

BMS; JPM26; early-stage bets; pipeline; Cobenfy; Milvexian; Admilparant; Pumitamig; Camzyos

JPM26 Day 1 Live Blog: Slow Deal Flow Amid Optimism at J.P. Morgan Healthcare Conference

17 hours ago talkbio0Tagged AI healthcare, Flow, J.P. Morgan Healthcare Conference, JPM26, M&A

JPM26; J.P. Morgan Healthcare Conference; deal flow; AI healthcare; biotech; M&A